September 10, 2025

Lung Cancer Under Siege in Spain: Timeliness, Treatment, and Survival Before and After the COVID-19 Pandemic.

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Retrospective cohort study assesses changes in lung cancer treatment and survival during the COVID-19 pandemic, highlighting resilience implications.

Lung cancer diagnoses fell by 19% in 2020, then rose by 42% in 2021, indicating disruptions but recovery trends.
Median referral-to-diagnosis time decreased significantly from 19 to 14 days, with over 80% diagnosed within 30 days spanning periods.
A retrospective cohort analysis involving 530 patients diagnosed with lung cancer from March 2019 to March 2022 evaluated critical intervals.
Despite the pandemic's challenges, survival rates improved over time, emphasizing the importance of early-stage diagnosis and health system resilience.

Blanco-Villar et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Retrospective cohort study assesses changes in lung cancer treatment and survival during the COVID-19 pandemic, highlighting resilience implications.